In alignment with a mission to broaden clinical trial access worldwide, Inato has seen major growth across its network in 2022.
Despite the nationwide incidence rate being lower than that of white women, Black women face a 41% higher death rate accompanying a breast cancer...
Community-based sites’ untapped patient populations, strong community bonds, and personal patient-physician relationships are the keys to unlocking...
With clinical trial budget negotiation being one of the biggest contributors to lost time during study start-up, a transformation towards efficiency...
Today’s clinical trials struggle to include diverse patient populations due to limited, centralized trial sites that are not easily accessible for...
Despite an overarching goal to save lives through medicine, the clinical trial industry leaves behind a crushing carbon footprint.
Striving for diversity across trials means striving for the inclusion of members of the LGBTQ+ community as well and recognizing gaps in research and...
Throughout Women’s History Month, we reached out to leaders in the clinical trial industry to hear their perspectives on women’s health and...
Despite making up 47% of the U.S. workforce, women only account for 28% of tech leadership positions. It’s a steady cycle of underrepresentation...
As the medical field has come to better understand gender disparities, the startling realization has emerged that many medications on the market...